Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.262
-0.023 (-8.04%)
At close: Apr 28, 2026, 4:00 PM EDT
0.270
+0.008 (2.94%)
Pre-market: Apr 29, 2026, 4:28 AM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $27.42 million as of April 28, 2026. Its market cap has decreased by -39.09% in one year.
Market Cap
27.42M
Enterprise Value
55.64M
1-Year Change
-39.09%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $27.42M, a decrease of -71.84%. That is a compound annual growth rate of -12.04%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 29.85M |
| Dyadic International | 29.61M |
| Senti Biosciences Holdings | 29.59M |
| Celularity | 29.42M |
| BriaCell Therapeutics | 29.18M |
| Lisata Therapeutics | 28.72M |
| Kyntra Bio | 28.57M |
| Tevogen Bio Holdings | 28.15M |